NTHI
NASDAQ
US
NeOnc Technologies Holdings, Inc. - Common Stock
$5.95
▼ $-0.14
(-2.30%)
Vol 99K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$198.2M
Beta
1.80
52W
$3–$25
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%
Next Report
May 07, 2026
EPS Estimate: $-0.31
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.31 | — | — |
| Dec 2025 | $-0.38 | $-0.73 | $-0.35 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | — | — | — | — | — |
| Current Ratio | 0.11 | 0.41 | 0.11 | 0.11 | 0.11 | 0.19 |
Key Ratios
ROA (TTM)
-1032.8%
EPS (TTM)
$-2.59
52W High
$25.00
52W Low
$3.20
$3.20
52-Week Range
$25.00
How does NTHI compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
NTHI valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
NTHI profitability vs Pharmaceuticals peers
ROE
—
▼
0%
below
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-1032.8%
▼
2658%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
NTHI financial health vs Pharmaceuticals peers
D/E ratio
—
▼
0%
below
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
0.2
▼
94%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.8
▲
91%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
NTHI fundamentals radar
NTHI
Peer median
Industry
NTHI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NTHI vs peers: key metrics
Latest News
No related news yet